Radiopharmaceuticals or medical radioactive compounds are a group of drugs containing radioisotopes. Radiopharmaceuticals can be used as diagnostic and therapeutic agents. Radiopharmaceuticals emit radiation by themselves, which is different from contrast agents that absorb or change external electromagnetic fields or ultrasound. Radiopharmacology is the branch of pharmacology that specializes in these drugs. The main group of these compounds are radiotracers used to diagnose body tissue dysfunction.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Nuclear Medicine & Radio Pharmaceuticals industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
Market Segment by Product Application
Diagnostic Applications: SPECT, PET.
Application 2
Finally, the report provides detailed profile and data information analysis of leading company.
GE Healthcare
Shimadzu
Toshiba
Philips Healthcare
Esaote
Siemens Healthcare
Biosensors International Group, Ltd
Carestream
Hitachi
TriFoil Imaging
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Nuclear Medicine & Radio Pharmaceuticals consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Nuclear Medicine & Radio Pharmaceuticals market by identifying its various subsegments.
3.Focuses on the key global Nuclear Medicine & Radio Pharmaceuticals manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Nuclear Medicine & Radio Pharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Nuclear Medicine & Radio Pharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Nuclear Medicine & Radio Pharmaceuticals Professional Survey Report Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Nuclear Medicine & Radio Pharmaceuticals Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Nuclear Medicine & Radio Pharmaceuticals Segment by Type
2.1.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
2.1.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
2.2 Market Analysis by Application
2.2.1 Diagnostic Applications: SPECT, PET.
2.2.2 Application 2
2.3 Global Nuclear Medicine & Radio Pharmaceuticals Market Comparison by Regions (2017-2027)
2.3.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Size (2017-2027)
2.3.2 North America Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2017-2027)
2.3.3 Europe Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2017-2027)
2.3.4 Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2017-2027)
2.3.5 South America Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Nuclear Medicine & Radio Pharmaceuticals Industry Impact
2.5.1 Nuclear Medicine & Radio Pharmaceuticals Business Impact Assessment - Covid-19
2.5.2 Market Trends and Nuclear Medicine & Radio Pharmaceuticals Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Nuclear Medicine & Radio Pharmaceuticals Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Nuclear Medicine & Radio Pharmaceuticals Manufacturer Market Share
3.5 Top 10 Nuclear Medicine & Radio Pharmaceuticals Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Nuclear Medicine & Radio Pharmaceuticals Market
3.7 Key Manufacturers Nuclear Medicine & Radio Pharmaceuticals Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Nuclear Medicine & Radio Pharmaceuticals Industry Key Manufacturers
4.1 GE Healthcare
4.1.1 Company Details
4.1.2 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
4.1.3 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 GE Healthcare News
4.2 Shimadzu
4.2.1 Company Details
4.2.2 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
4.2.3 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Shimadzu News
4.3 Toshiba
4.3.1 Company Details
4.3.2 Toshiba Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
4.3.3 Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Toshiba News
4.4 Philips Healthcare
4.4.1 Company Details
4.4.2 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
4.4.3 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Philips Healthcare News
4.5 Esaote
4.5.1 Company Details
4.5.2 Esaote Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
4.5.3 Esaote Nuclear Medicine & Radio Pharmaceuticals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Esaote News
4.6 Siemens Healthcare
4.6.1 Company Details
4.6.2 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
4.6.3 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Siemens Healthcare News
4.7 Biosensors International Group, Ltd
4.7.1 Company Details
4.7.2 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
4.7.3 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Biosensors International Group, Ltd News
4.8 Carestream
4.8.1 Company Details
4.8.2 Carestream Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
4.8.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Carestream News
4.9 Hitachi
4.9.1 Company Details
4.9.2 Hitachi Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
4.9.3 Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Hitachi News
4.10 TriFoil Imaging
4.10.1 Company Details
4.10.2 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
4.10.3 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 TriFoil Imaging News
5 Global Nuclear Medicine & Radio Pharmaceuticals Sales Categorized by Regions
5.1 Global Nuclear Medicine & Radio Pharmaceuticals Revenue, Sales and Market Share by Regions
5.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Regions (2017-2022)
5.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Regions (2017-2022)
5.2 North America Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
5.3 Europe Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
5.5 South America Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
6 North America Nuclear Medicine & Radio Pharmaceuticals Market Size Categorized by Countries
6.1 North America Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Countries
6.1.1 North America Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) by Countries (2017-2022)
6.1.2 North America Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2017-2022)
6.1.3 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
6.1.4 Canada Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
6.1.5 Mexico Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
6.2 North America Nuclear Medicine & Radio Pharmaceuticals Revenue (Value) by Manufacturers
6.3 North America Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Type (2017-2022)
6.4 North America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2017-2022)
7 Europe Nuclear Medicine & Radio Pharmaceuticals Market Size Categorized by Countries
7.1 Europe Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Countries
7.1.1 Europe Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2017-2022)
7.1.3 Germany Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
7.1.4 UK Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
7.1.5 France Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
7.1.6 Russia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
7.1.7 Italy Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
7.1.8 Spain Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
7.2 Europe Nuclear Medicine & Radio Pharmaceuticals Revenue (Value) by Manufacturers
7.3 Europe Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Type (2017-2022)
7.4 Europe Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2017-2022)
8 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Size Categorized by Countries
8.1 Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2017-2022)
8.1.3 China Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
8.1.4 South Korea Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
8.1.5 Japan Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
8.1.6 Australia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
8.1.7 India Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Revenue (Value) by Manufacturers
8.3 Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2017-2022)
9 South America Nuclear Medicine & Radio Pharmaceuticals Market Size Categorized by Countries
9.1 South America Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Countries
9.1.1 South America Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) by Countries (2017-2022)
9.1.2 South America Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2017-2022)
9.1.3 Brazil Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
9.2 South America Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Type (2017-2022)
9.3 South America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2017-2022)
10 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Size Categorized by Countries
10.1 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2017-2022)
10.1.3 GCC Countries Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
10.1.4 Turkey Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
10.1.5 Egypt Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
10.1.6 South America Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Type
10.3 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2017-2022)
11 Global Nuclear Medicine & Radio Pharmaceuticals Market Segment by Type
11.1 Global Nuclear Medicine & Radio Pharmaceuticals Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Type (2017-2022)
11.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Type (2017-2022)
11.2 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Sales Growth Rate and Price
11.2.1 Global Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Sales Growth Rate (2017-2022)
11.2.2 Global Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Price (2017-2022)
11.3 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Sales Growth Rate and Price
11.3.1 Global Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Sales Growth Rate (2017-2022)
11.3.2 Global Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Price (2017-2022)
12 Global Nuclear Medicine & Radio Pharmaceuticals Market Segment by Application
12.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2017-2022)
12.2 Diagnostic Applications: SPECT, PET. Sales Growth Rate (2017-2022)
12.3 Application 2 Sales Growth Rate (2017-2022)
13 Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast
13.1 Global Nuclear Medicine & Radio Pharmaceuticals Revenue, Sales and Growth Rate (2022-2027)
13.2 Nuclear Medicine & Radio Pharmaceuticals Market Forecast by Regions (2022-2027)
13.2.1 North America Nuclear Medicine & Radio Pharmaceuticals Market Forecast (2022-2027)
13.2.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Forecast (2022-2027)
13.2.3 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Forecast (2022-2027)
13.2.4 South America Nuclear Medicine & Radio Pharmaceuticals Market Forecast (2022-2027)
13.2.5 Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Market Forecast (2022-2027)
13.3 Nuclear Medicine & Radio Pharmaceuticals Market Forecast by Type (2022-2027)
13.3.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales Forecast by Type (2022-2027)
13.3.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Share Forecast by Type (2022-2027)
13.4 Nuclear Medicine & Radio Pharmaceuticals Market Forecast by Application (2022-2027)
13.4.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales Forecast by Application (2022-2027)
13.4.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Share Forecast by Application (2022-2027)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Nuclear Medicine & Radio Pharmaceuticals Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Nuclear Medicine & Radio Pharmaceuticals Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Nuclear Medicine & Radio Pharmaceuticals
Figure Market Concentration Ratio and Market Maturity Analysis of Nuclear Medicine & Radio Pharmaceuticals
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Size by Type
Figure Global Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type in 2021
Figure Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Picture
Figure Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Picture
Table Global Nuclear Medicine & Radio Pharmaceuticals Market Size (Volume) by Application
Figure Diagnostic Applications: SPECT, PET. Picture
Figure Application 2 Picture
Table Global Nuclear Medicine & Radio Pharmaceuticals Comparison by Regions (M USD) 2017-2027
Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Size (Million US$) (2017-2027)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Nuclear Medicine & Radio Pharmaceuticals Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales by Manufacturer (2017-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Manufacturer in 2021
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Manufacturer (2017-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Manufacturer in 2021
Table Global Nuclear Medicine & Radio Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Nuclear Medicine & Radio Pharmaceuticals Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Nuclear Medicine & Radio Pharmaceuticals Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Nuclear Medicine & Radio Pharmaceuticals Market
Table Key Manufacturers Nuclear Medicine & Radio Pharmaceuticals Product Type
Table Mergers & Acquisitions Planning
Table GE Healthcare Company Profile
Table Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification of GE Healthcare
Table Nuclear Medicine & Radio Pharmaceuticals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of GE Healthcare 2017-2022
Table GE Healthcare Main Business
Table GE Healthcare Recent Development
Table Shimadzu Company Profile
Table Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification of Shimadzu
Table Nuclear Medicine & Radio Pharmaceuticals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Shimadzu 2017-2022
Table Shimadzu Main Business
Table Shimadzu Recent Development
Table Toshiba Company Profile
Table Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification of Toshiba
Table Nuclear Medicine & Radio Pharmaceuticals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Toshiba 2017-2022
Table Toshiba Main Business
Table Toshiba Recent Development
Table Philips Healthcare Company Profile
Table Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification of Philips Healthcare
Table Nuclear Medicine & Radio Pharmaceuticals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Philips Healthcare 2017-2022
Table Philips Healthcare Main Business
Table Philips Healthcare Recent Development
Table Esaote Company Profile
Table Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification of Esaote
Table Nuclear Medicine & Radio Pharmaceuticals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Esaote 2017-2022
Table Esaote Main Business
Table Esaote Recent Development
Table Siemens Healthcare Company Profile
Table Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification of Siemens Healthcare
Table Nuclear Medicine & Radio Pharmaceuticals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Siemens Healthcare 2017-2022
Table Siemens Healthcare Main Business
Table Siemens Healthcare Recent Development
Table Biosensors International Group, Ltd Company Profile
Table Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification of Biosensors International Group, Ltd
Table Nuclear Medicine & Radio Pharmaceuticals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biosensors International Group, Ltd 2017-2022
Table Biosensors International Group, Ltd Main Business
Table Biosensors International Group, Ltd Recent Development
Table Carestream Company Profile
Table Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification of Carestream
Table Nuclear Medicine & Radio Pharmaceuticals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Carestream 2017-2022
Table Carestream Main Business
Table Carestream Recent Development
Table Hitachi Company Profile
Table Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification of Hitachi
Table Nuclear Medicine & Radio Pharmaceuticals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Hitachi 2017-2022
Table Hitachi Main Business
Table Hitachi Recent Development
Table TriFoil Imaging Company Profile
Table Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification of TriFoil Imaging
Table Nuclear Medicine & Radio Pharmaceuticals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of TriFoil Imaging 2017-2022
Table TriFoil Imaging Main Business
Table TriFoil Imaging Recent Development
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2017-2022)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales by Regions (2017-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Regions in 2021
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Regions (2017-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions in 2021
Figure North America Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure South America Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2017-2022)
Table North America Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) by Countries (2017-2022)
Table North America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2017-2022)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries in 2021
Table North America Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2017-2022)
Table North America Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2017-2022)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries in 2021
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure Canada Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure Mexico Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Table North America Nuclear Medicine & Radio Pharmaceuticals Revenue by Manufacturer (2021)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Manufacturer in 2021
Table North America Nuclear Medicine & Radio Pharmaceuticals Sales by Type (2017-2022)
Table North America Nuclear Medicine & Radio Pharmaceuticals Sales Share by Type (2017-2022)
Table North America Nuclear Medicine & Radio Pharmaceuticals Sales by Application (2017-2022)
Table North America Nuclear Medicine & Radio Pharmaceuticals Sales Share by Application (2017-2022)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2017-2022)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) by Countries (2017-2022)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2017-2022)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries in 2021
Table Europe Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2017-2022)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2017-2022)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries in 2021
Figure Germany Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure UK Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure France Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure Russia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure Italy Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure Spain Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Revenue by Manufacturer (2021)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Manufacturer in 2021
Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales by Type (2017-2022)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales Share by Type (2017-2022)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales by Application (2017-2022)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales Share by Application (2017-2022)
Figure Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2017-2022)
Table Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries in 2021
Table Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2017-2022)
Table Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries in 2021
Figure China Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure South Korea Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure Australia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure India Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Table Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Revenue by Manufacturer (2021)
Figure Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Sales by Type (2017-2022)
Table Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Sales Share by Type (2017-2022)
Table Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Sales by Application (2017-2022)
Table Asia-pacific Nuclear Medicine & Radio Pharmaceuticals Sales Share by Application (2017-2022)
Figure South America Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2017-2022)
Table South America Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) by Countries (2017-2022)
Table South America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2017-2022)
Figure South America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries in 2019
Table South America Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2017-2022)
Table South America Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2017-2022)
Figure South America Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries in 2019
Figure Brazil Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Table South America Nuclear Medicine & Radio Pharmaceuticals Sales by Type (2017-2022)
Table South America Nuclear Medicine & Radio Pharmaceuticals Sales Share by Type (2017-2022)
Table South America Nuclear Medicine & Radio Pharmaceuticals Revenue by Type (2017-2022)
Table South America Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Type (2017-2022)
Table South America Nuclear Medicine & Radio Pharmaceuticals Sales by Application (2017-2022)
Table South America Nuclear Medicine & Radio Pharmaceuticals Sales Share by Application (2017-2022)
Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries in 2019
Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2017-2022)
Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries in 2019
Figure GCC Countries Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure Turkey Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure Egypt Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Figure South Africa Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2017-2022)
Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales by Type (2017-2022)
Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales Share by Type (2017-2022)
Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue by Type (2017-2022)
Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Type (2017-2022)
Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales by Application (2017-2022)
Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales Share by Application (2017-2022)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales by Type (2017-2022)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type (2017-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type in 2021
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Type (2017-2022)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Type (2017-2022)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Type in 2019
Figure Global Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Sales Growth Rate (2017-2022)
Figure Global Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Price (2017-2022)
Figure Global Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Sales Growth Rate (2017-2022)
Figure Global Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Price (2017-2022)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales by Application (2017-2022)
Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2017-2022)
Figure Global Nuclear
GE Healthcare
Shimadzu
Toshiba
Philips Healthcare
Esaote
Siemens Healthcare
Biosensors International Group, Ltd
Carestream
Hitachi
TriFoil Imaging